Atilla, E. Et Al. 2019. Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?. Hematology/ Oncology and Stem Cell Therapy , vol.12, no.4 , 220-225.

Atilla, E., Sahin, U., Atilla, P. A., Merter, M., PEKER, E., CEYHAN, K., ... CİVRİZ BOZDAĞ, S.(2019). Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?. Hematology/ Oncology and Stem Cell Therapy , vol.12, no.4, 220-225.

Atilla, Erden Et Al. "Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?," Hematology/ Oncology and Stem Cell Therapy , vol.12, no.4, 220-225, 2019

Atilla, Erden Et Al. "Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?." Hematology/ Oncology and Stem Cell Therapy , vol.12, no.4, pp.220-225, 2019

Atilla, E. Et Al. (2019) . "Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?." Hematology/ Oncology and Stem Cell Therapy , vol.12, no.4, pp.220-225.

@article{article, author={Erden Atilla Et Al. }, title={Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?}, journal={Hematology/ Oncology and Stem Cell Therapy}, year=2019, pages={220-225} }